Meropenem Pontus Pharma D.O.O.

Meropenem, the active ingredient in Meropenem Pontus Pharma D.O.O., is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia and septicemia in hospitalized patients.

GNH USA supplies Meropenem Pontus Pharma D.O.O. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic used for serious bacterial infections in the hospital setting.

- Complicated intra‑abdominal infections: achieves bacterial eradication and clinical cure in patients with perforated or postoperative abdominal infections. - Complicated urinary tract infections: eliminates resistant Gram‑negative pathogens causing severe UTIs. - Nosocomial pneumonia: provides effective coverage against hospital‑acquired respiratory pathogens. - Septicemia: rapidly reduces bacteremia and improves survival in systemic infections.

Meropenem may cause a range of adverse reactions, ranging from mild to severe.

Common Side Effects: - Diarrhea: mild to moderate gastrointestinal upset. - Nausea: occasional feeling of queasiness. - Headache: transient cranial discomfort. - Rash: mild skin erythema. - Elevated liver enzymes: transient increase in hepatic transaminases. - Injection site pain: discomfort at the IV site.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: especially in patients with renal impairment or CNS disorders. - Clostridioides difficile colitis: severe intestinal infection. - Thrombocytopenia: low platelet count leading to bleeding risk. - Renal dysfunction: acute kidney injury in susceptible individuals.

When using Meropenem, clinicians should consider several safety measures.

- Renal function: adjust dose in patients with impaired kidney function. - Hepatic function: monitor liver enzymes during prolonged therapy. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk, as safety data are limited. - Concomitant nephrotoxic drugs: avoid or monitor closely to reduce kidney injury risk. - Allergies: assess for a history of β‑lactam hypersensitivity before initiation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Valproic acid: may reduce serum valproate levels, risking seizure breakthrough. - Probenecid: can increase meropenem plasma concentrations, heightening toxicity risk.

Moderate Interactions (Monitor Closely): - Aminoglycosides: combined nephrotoxic potential; monitor renal function. - Loop diuretics: may enhance ototoxicity when used together. - Anticoagulants (e.g., warfarin): possible alteration of INR; check coagulation parameters.